Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Life Sci ; 81(6): 441-8, 2007 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-17662308

RESUMEN

Human NT cells derived from the NTera2/D1 cell line express a dopaminergic phenotype making them an attractive vehicle to supply dopamine to the depleted striatum of the Parkinsonian patient. In vitro, hNT neurons express tyrosine hydroxylase (TH), depending on the length of time they are exposed to retinoic acid. This study compared two populations of hNT neurons that exhibit a high yield of TH+ cells, MI-hNT and DA-hNT. The MI-hNT and DA-hNT neurons were intrastriatally transplanted into the 6-OHDA hemiparkinsonian rat. Amelioration in rotational behavior was measured and immunohistochemistry was performed to identify surviving hNT and TH+ hNT neurons. Results indicated that both MI-hNT and DA-hNT neurons can survive in the striatum, however, neither maintained their dopaminergic phenotype in vivo. Other strategies used in conjunction with hNT cell replacement are likely needed to enhance and maintain the dopamine expression in the grafted cells.


Asunto(s)
Trasplante de Células/fisiología , Dopamina/fisiología , Enfermedad de Parkinson Secundaria/fisiopatología , Receptores de Dopamina D1/fisiología , Animales , Apomorfina/toxicidad , Conducta Animal/efectos de los fármacos , Línea Celular , Agonistas de Dopamina/toxicidad , Supervivencia de Injerto , Humanos , Procesamiento de Imagen Asistido por Computador , Inmunohistoquímica , Oxidopamina , Enfermedad de Parkinson Secundaria/inducido químicamente , Ratas , Ratas Sprague-Dawley , Receptores de Dopamina D1/genética , Conducta Estereotipada/efectos de los fármacos , Simpaticolíticos , Tirosina 3-Monooxigenasa/biosíntesis , Tirosina 3-Monooxigenasa/genética
2.
J Neurosci Res ; 83(4): 668-79, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16408307

RESUMEN

Our laboratory is working with the human NTera2/D1 (NT2) cell line, which has properties similar to those of progenitor cells in the central nervous system (CNS). These neural-like precursor cells can differentiate into all three major lineages, neurons, astrocytes, and oligodendrocytes. The pure neuronal population, hNT neurons, possess characteristics of dopamine (DA) cells. First, we analyzed whether the retinoic acid (RA)-treated hNT neurons and the NT2 precursor cells expressed two transcription factors required for development of the midbrain DA neurons. We report that NT2 cells endogenously expressed Engrailed-1 and Ptx3, whereas RA-treated hNT neurons did not express Engrailed-1 or Ptx3. Next we examined the influence of lithium treatment on Engrailed-1 and Ptx3 as well as another critical transcription factor, Nurr1. Previous research has shown that lithium can mimic the Wnt pathway, which is important for the induction of these transcription factors. Finally, we investigated the effect of lithium treatment on the viability and proliferation of NT2 cells, because lithium has been shown to stimulate neurogenesis in adult neural precursors. Lithium treatment increased the viability and proliferation of NT2 cells. The expression of transcription factors essential for the induction and maintenance of the DA phenotype was not increased in NT2 after lithium treatment. We conclude that the NT2 cell line is an excellent in vitro model system for studying the influence of pharmalogical agents on proliferation, differentiation, and apoptosis of a human neural progenitor cell line.


Asunto(s)
Antineoplásicos/farmacología , Dopamina/fisiología , Litio/farmacología , Tretinoina/farmacología , Apoptosis/efectos de los fármacos , Western Blotting , Proteína C-Reactiva/genética , Recuento de Células , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Proteínas de Unión al ADN/genética , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3/metabolismo , Proteínas de Homeodominio/genética , Humanos , Inmunohistoquímica , Miembro 2 del Grupo A de la Subfamilia 4 de Receptores Nucleares , Componente Amiloide P Sérico/genética , Transducción de Señal/efectos de los fármacos , Factores de Transcripción/genética , beta Catenina/metabolismo
3.
J Neurosci Res ; 76(2): 244-54, 2004 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-15048922

RESUMEN

Hematopoietic progenitors are cells, which under challenging experimental conditions can develop unusual phenotypic properties, rather distant from their original mesodermal origin. As previously reported, cells derived from human umbilical cord blood (HUCB) or human bone marrow (BM) under certain in vivo or in vitro conditions can manifest neural features that resemble features of neural-derived cells, immunocytochemically and in some instances also morphologically. The present study explored how hematopoietic-derived cells would respond to neurogenic signals from the subventricular zone (SVZ) of adult and aged (6 and 16 months old) rats. The mononuclear fraction of HUCB cells was transplanted into the SVZ of immunosuppressed (single cyclosporin or three-drug treatment) animals. The triple-suppression paradigm allowed us to protect transplanted human cells within the brain and to explore further their phenotypic and migratory properties. One week after implantation, many surviving HUCB cells were located within the SVZ and the vertical limb of the rostral migratory stream (RMS). The migration of HUCB cells was restricted exclusively to the pathway leading to the olfactory bulb. In younger animals, grafted cells navigated almost halfway through the vertical limb, whereas, in the older animals, the migration was less pronounced. The overall cell survival was greater in younger animals than in older ones. Immunocytochemistry for surface CD antigen expression showed that many HUCB cells, either cultured or within the brain parenchyma, retained their hematopoietic identity. A few cells, identified by using human-specific antibodies (anti-human nuclei, or mitochondria) expressed nestin and doublecortin, markers of endogenous neural progenitors. Therefore, it is believed that the environment of the neurogenic SVZ, even in aged animals, was able to support survival, "neuralization," and migratory features of HUCB-derived cells.


Asunto(s)
Antígenos CD , Antígenos de Neoplasias , Antígenos de Superficie , Proteínas Aviares , Proteínas Sanguíneas , Diferenciación Celular , Ambiente , Células Madre Hematopoyéticas/fisiología , Células Madre Multipotentes/trasplante , Neuronas/metabolismo , Factores de Edad , Animales , Basigina , Células de la Médula Ósea/fisiología , Recuento de Células , Movimiento Celular/fisiología , Supervivencia Celular/fisiología , Células Cultivadas , Ventrículos Cerebrales/metabolismo , Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Proteína Doblecortina , Proteína Ácida Fibrilar de la Glía/metabolismo , Proteínas Fluorescentes Verdes , Humanos , Inmunohistoquímica/métodos , Inmunosupresores/farmacología , Indoles/metabolismo , Antígenos Comunes de Leucocito/metabolismo , Proteínas Luminiscentes/metabolismo , Masculino , Glicoproteínas de Membrana/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Células Madre Multipotentes/citología , Células Madre Multipotentes/efectos de los fármacos , Células Madre Multipotentes/fisiología , Neuronas/química , Fenotipo , Ratas , Ratas Endogámicas F344 , Tubulina (Proteína)/metabolismo
4.
J Neurosci Res ; 76(2): 255-64, 2004 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-15048923

RESUMEN

Finding a reliable source of alternative neural stem cells for treatment of various diseases and injuries affecting the central nervous system is a challenge. Numerous studies have shown that hematopoietic and nonhematopoietic progenitors derived from bone marrow (BM) under specific conditions are able to differentiate into cells of all three germ layers. Recently, it was reported that cultured, unfractionated (whole) adult BM cells form nestin-positive spheres that can later initiate neural differentiation (Kabos et al., 2002). The identity of the subpopulation of BM cells that contributes to neural differentiation remains unknown. We therefore analyzed the hematopoietic and neural features of cultured, unfractionated BM cells derived from a transgenic mouse that expresses green fluorescent protein (GFP) in all tissues. We also transplanted the BM cells into the subventricular zone (SVZ), a region known to support postnatal neurogenesis. After injection of BM cells into the neurogenic SVZ in neonatal rats, we found surviving GFP+ BM cells close to the injection site and in various brain regions, including corpus callosum and subcortical white matter. Many of the grafted cells were detected within the rostral migratory stream (RMS), moving toward the olfactory bulb (OB), and some cells reached the subependymal zone of the OB. Our in vitro experiments revealed that murine GFP+ BM cells retained their proliferation and differentiation potential and predominantly preserved their hematopoietic identity (CD45, CD90, CD133), although a few expressed neural antigens (nestin, glial fibrillary acdiic protein, TuJ1).


Asunto(s)
Células de la Médula Ósea/metabolismo , Encéfalo/metabolismo , Hematopoyesis/fisiología , Proteínas Luminiscentes/metabolismo , Neuronas/metabolismo , Animales , Animales Recién Nacidos , Encéfalo/citología , Bromodesoxiuridina/metabolismo , Recuento de Células/métodos , Supervivencia Celular , Células Cultivadas , Femenino , Proteínas Fluorescentes Verdes , Inmunohistoquímica/métodos , Proteínas Luminiscentes/genética , Masculino , Ratones , Ratones Transgénicos , Embarazo , Ratas , Ratas Sprague-Dawley , Trasplante de Células Madre/métodos , Factores de Tiempo
5.
Exp Neurol ; 185(1): 191-7, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-14697330

RESUMEN

Bone marrow stromal cells (BMSC) have been shown to generate neural cells under experimental conditions in vitro and following transplantation into animal models of stroke and traumatic CNS injury. Hastened recovery from the neurological deficit has not correlated with structural repair of the lesion in the stroke model. Secretory functions of BMSC, such as the elaboration of growth factors and cytokines, have been hypothesized to play a role in the enhanced recovery of neurological function. Using gene expression arrays, real time RT-PCR and radioimmunoassay, we have found that brain natriuretic peptide (BNP) is synthesized and released by BMSC at physiologically relevant levels in vitro. BNP, like its close homolog atrial natriuretic peptide (ANP), exerts powerful natriuretic, diuretic and vasodilatory effects. We speculate that transplanted BMSCs facilitate recovery from brain and spinal cord lesions by releasing BNP and other vasoactive factors that reduce edema, decrease intracranial pressure and improve cerebral perfusion.


Asunto(s)
Células de la Médula Ósea/metabolismo , Péptido Natriurético Encefálico/biosíntesis , Células del Estroma/metabolismo , Adulto , Células de la Médula Ósea/citología , Células de la Médula Ósea/efectos de los fármacos , Técnicas de Cultivo de Célula/métodos , Diferenciación Celular/efectos de los fármacos , Diferenciación Celular/fisiología , Células Cultivadas , Factor de Crecimiento Epidérmico/farmacología , Femenino , Factores de Crecimiento de Fibroblastos/farmacología , Humanos , Masculino , Persona de Mediana Edad , Péptido Natriurético Encefálico/genética , Factor de Crecimiento Nervioso/farmacología , ARN Mensajero/biosíntesis , Radioinmunoensayo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células del Estroma/citología , Células del Estroma/efectos de los fármacos , Tretinoina/farmacología
6.
J Neurosci Res ; 73(3): 296-307, 2003 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-12868063

RESUMEN

Human umbilical cord blood (hUCB) is a rich source of hematopoietic stem cells that have been used to reconstitute immune cells and blood lineages. Cells from another hematopoietic source, bone marrow, have been found to differentiate into neural cells and are effective in the treatment of stroke. In this study, we administered hUCB cells intravenously into the femoral vein or directly into the striatum and assessed which route of cell administration produced the greatest behavioral recovery in rats with permanent middle cerebral artery occlusion (MCAO). All animals were immunosuppressed with cyclosporine (CSA). When spontaneous activity was measured using the Digiscan automated system, it was found to be significantly less when hUCB was transplanted 24 hr after stroke compared with nontransplanted, stroked animals (P < 0.01). Furthermore, behavioral recovery was similar with both striatal and femoral hUCB delivery. This is in contrast to the step test, in which significant improvements were found only after femoral delivery of the hUCB cells. In the passive avoidance test, transplanted animals learned the task faster than nontransplanted animals (P < 0.05). Together, these results suggest that hUCB transplantation may be an effective treatment for brain injuries, such as stroke, or neurodegenerative disorders. In addition, intravenous delivery may be more effective than striatal delivery in producing long-term functional benefits to the stroked animal.


Asunto(s)
Trasplante de Células Madre de Sangre del Cordón Umbilical/métodos , Cuerpo Estriado/citología , Infarto de la Arteria Cerebral Media/terapia , Animales , Reacción de Prevención , Conducta Animal , Ritmo Circadiano , Vena Femoral , Inmunohistoquímica , Infarto de la Arteria Cerebral Media/patología , Inyecciones Intravenosas , Masculino , Microinyecciones , Actividad Motora , Ratas , Ratas Sprague-Dawley
7.
J Neurobiol ; 50(4): 305-22, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11891665

RESUMEN

The interneurons of the olfactory bulb arise from precursor cells in the anterior part of the neonatal subventricular zone, the SVZa, and are distinctive in that they possess a neuronal phenotype and yet undergo cell division. To characterize the differentiation of neonatal SVZa progenitor cells, we analyzed the complement of ionotropic neurotransmitter receptors that they express in vitro. For this analysis, we tested the sensitivity of SVZa progenitor cells to gamma-amino-n-butyric acid (GABA), adenosine triphosphate (ATP), kainate, N-methyl-D-aspartate (NMDA), and acetylcholine (ACh) after 1 day in vitro. SVZa progenitor cells had chloride currents activated by GABA and muscimol, the GABA(A) receptor-specific agonist, but were insensitive to ATP, kainate, NMDA, and ACh. In addition, GABA- or muscimol-activated chloride currents were blocked nearly completely by 30 microM bicuculline, the GABA(A) receptor-specific antagonist, suggesting that GABA(B) and GABA(C) receptors are absent. Measurements of the chloride reversal potential by gramicidin-perforated patch clamp revealed that currents generated by activation of GABA(A) receptors were inward, and thus, depolarizing. A set of complementary experiments was undertaken to determine by reverse transcription and polymerase chain reaction (RT-PCR) whether SVZa progenitor cells express the messenger RNA (mRNA) coding for glutamic acid decarboxylase 67 (GAD67), used in the synthesis of GABA and for GABA(A) receptor subunits. Both postnatal day (P0) SVZa and olfactory bulb possessed detectable mRNA coding for GAD67. In P0 SVZa, the GABA(A) receptor subunits detected with RT-PCR included alpha 2-4, beta 1-3, and gamma 2S (short form). By comparison, the P0 olfactory bulb expressed all of the subunits detectable in the SVZa and additional subunit mRNAs: alpha 1, alpha 5, gamma 1, gamma 2L (long form), gamma 3, and delta subunit mRNAs. Antibodies recognizing GABA, GAD, and various GABA(A) receptor subunits were used to label SVZa cells harvested from P0-1 rats and cultured for 1 day. The cells were immunoreactive for GABA, GAD, and the GABA(A) receptor subunits alpha 2-5, beta 1-3, and gamma 2. To relate the characteristics of GABA(A) receptors in cultured SVZa precursor cells to particular combinations of subunits, the open reading frames of the dominant subunits detected by RT-PCR (alpha 2-4, beta 3, and gamma 2S) were cloned into a mammalian cell expression vector and different combinations were transfected into Chinese hamster ovary-K1 (CHO-K1) cells. A comparison of the sensitivity to inhibition by zinc of GABA(A) receptors in SVZa precursor cells and in CHO-K1 cells expressing various combinations of recombinant GABA(A) receptor subunits suggested that the gamma 2S subunit was present and functional in the GABA(A) receptor chloride channel complex. Thus, SVZa precursor cells are GABAergic and a subset of the GABA(A) receptor subunits detected in the olfactory bulb was found in the SVZa, as might be expected because SVZa progenitor cells migrate to the bulb as they differentiate.


Asunto(s)
Diferenciación Celular/genética , Movimiento Celular/genética , Neuronas/metabolismo , Bulbo Olfatorio/crecimiento & desarrollo , Bulbo Olfatorio/metabolismo , Receptores de GABA-A/genética , Células Madre/metabolismo , Ácido gamma-Aminobutírico/metabolismo , Animales , Animales Recién Nacidos , Diferenciación Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Canales de Cloruro/efectos de los fármacos , Canales de Cloruro/metabolismo , Glutamato Descarboxilasa/genética , Isoenzimas/genética , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Neuronas/citología , Bulbo Olfatorio/citología , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo , Ratas , Receptores de GABA-A/efectos de los fármacos , Receptores de GABA-A/metabolismo , Proteínas Recombinantes/efectos de los fármacos , Proteínas Recombinantes/metabolismo , Células Madre/citología , Células Madre/efectos de los fármacos , Zinc/farmacología , Ácido gamma-Aminobutírico/farmacología
8.
Brain Res Bull ; 56(2): 147-52, 2001 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-11704352

RESUMEN

Bcl-2 encodes membrane-associated proteins that suppress programmed cell death in cells of various origins. Compelling evidence suggests that bcl-2 is also involved in neuronal differentiation and axonal regeneration. The human Neuro-Teratocarcinoma (hNT) neurons constitute a terminally differentiated human neuronal cell line that is derived from the Ntera-2/clone D1 (NT2) precursors upon retinoic acid (RA) treatment. After transplantation into the central nervous system (CNS), the hNT neurons survive, engraft, maintain their neuronal identity, and extend long neurite outgrowth. We were particularly interested in the intracellular determinants that confer these post-transplant characteristics to the hNT neurons. Thus, we asked whether the hNT neurons express bcl-2 after transplantation into the rat striatum and if RA induction of the neuronal lineage is mediated by bcl-2. The grafted hNT neurons were first identified using three different antibodies that recognize human-specific epitopes, anti-hMit, anti-hNuc, and NuMA. After a 1-month post-transplant survival time, NuMA immunostaining revealed that 12% of the hNT neurons survived the transplantation. These neurons extended long neuritic processes within the striatum, as demonstrated using the human-specific antibody against the midsize neurofilament subunit HO14. Importantly, we found that 85% of the implanted hNT neurons expressed bcl-2 and that the in vitro induction of the neuronal lineage from the NT2 precursors with RA resulted in an upregulation of bcl-2 expression. Together, these data suggest that the differentiation of the hNT neurons to a neuronal lineage could be mediated at least partially by bcl-2.


Asunto(s)
Diferenciación Celular/fisiología , Linaje de la Célula/fisiología , Supervivencia de Injerto/fisiología , Neuronas/trasplante , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Trasplante de Células Madre , Animales , Antígenos Nucleares , Trasplante de Tejido Encefálico , Proteínas de Ciclo Celular , Diferenciación Celular/efectos de los fármacos , Linaje de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Regulación de la Expresión Génica/fisiología , Proteínas Facilitadoras del Transporte de la Glucosa , Supervivencia de Injerto/efectos de los fármacos , Humanos , Inmunohistoquímica , Masculino , Proteínas de la Membrana/metabolismo , Proteínas de Transporte de Monosacáridos/metabolismo , Neostriado/crecimiento & desarrollo , Neostriado/metabolismo , Neostriado/cirugía , Neuritas/efectos de los fármacos , Neuritas/metabolismo , Neuritas/ultraestructura , Proteínas de Neurofilamentos/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Proteínas Asociadas a Matriz Nuclear , Proteínas Nucleares/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Células Madre/efectos de los fármacos , Células Madre/metabolismo , Tretinoina/farmacología , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismo , Células Tumorales Cultivadas/trasplante , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/fisiología
9.
Adv Neurol ; 86: 435-45, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11554006

RESUMEN

In conclusion, proof of the principle exists that neural grafts can survive transplantation in PD and that this graft survival is related to preliminary evidence of clinical benefit and improvement on FD-PET. Two prospective, randomized, surgical placebo-controlled trials of fetal tissue transplantation for the treatment of PD will be published in the near future, as will results of a placebo-controlled xenograft trial. Lifelong survival of human fetal nigral grafts is likely. The striatum is comparatively simple to target surgically in comparison to other sites such as the subthalamic nucleus. Several new sources of dopamine cells are being developed for transplantation purposes. Long-term monitoring for toxicity, such as the development of dyskinesias, will be needed, and dose-escalation trials should be performed slowly due to the irreversible nature of transplants. There are numerous ways to improve current techniques of neural transplantation.


Asunto(s)
Trasplante de Tejido Encefálico , Trasplante de Tejido Fetal , Enfermedad de Parkinson/cirugía , Humanos
10.
Exp Neurol ; 171(1): 109-15, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11520125

RESUMEN

A population of cells derived from human and rodent bone marrow has been shown by several groups of investigators to give rise to glia and neuron-like cells. Here we show that human umbilical cord blood cells treated with retinoic acid (RA) and nerve growth factor (NGF) exhibited a change in phenotype and expressed molecular markers usually associated with neurons and glia. Musashi-1 and beta-tubulin III, proteins found in early neuronal development, were expressed in the induced cord blood cells. Other molecules associated with neurons in the literature, such as glypican 4 and pleiotrophin mRNA, were detected using DNA microarray analysis and confirmed independently with reverse transcriptase polymerase chain reaction (RT-PCR). Glial fibrillary acidic protein (GFAP) and its mRNA were also detected in both the induced and untreated cord blood cells. Umbilical cord blood appears to be more versatile than previously known and may have therapeutic potential for neuronal replacement or gene delivery in neurodegenerative diseases, trauma, and genetic disorders.


Asunto(s)
Antígenos de Diferenciación/biosíntesis , Sangre Fetal/citología , Sangre Fetal/metabolismo , Leucocitos Mononucleares/metabolismo , Antígenos de Diferenciación/genética , Western Blotting , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/genética , Recuento de Células , Células Cultivadas , Citocinas/biosíntesis , Citocinas/genética , Proteína Ácida Fibrilar de la Glía/biosíntesis , Proteína Ácida Fibrilar de la Glía/genética , Glipicanos , Proteoglicanos de Heparán Sulfato/biosíntesis , Proteoglicanos de Heparán Sulfato/genética , Humanos , Inmunohistoquímica , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/efectos de los fármacos , Factor de Crecimiento Nervioso/farmacología , Proteínas del Tejido Nervioso/biosíntesis , Análisis de Secuencia por Matrices de Oligonucleótidos , Fenotipo , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Proteínas de Unión al ARN/biosíntesis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tretinoina/farmacología , Tubulina (Proteína)/biosíntesis
11.
Int J Neurosci ; 108(1-2): 55-67, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11328702

RESUMEN

Taurine acts as an antioxidant protecting neurons from free radical-mediated cellular damage. 3-nitropropionic acid (3-NP) inhibits energy metabolism, initiating oxidative stress. With the objective to examine whether taurine can protect glia and neurons from damage produced by 3-NP, male Wistar and Sprague-Dawley rats were treated with either (1) saline, (2) taurine (3) 3-NP and saline, or (4) 3-NP and taurine for 4 days. Survival was determined and brains were processed immunohistochemically. Large striatal lesions and increased GFAP, SOD, and taurine immunoreactivity were detected in the 3-NP group when compared with control groups. In contrast, animals receiving 3-NP and taurine exhibited less GFAP, SOD, and taurine immunoreactivity, along with increased survival rates. Results indicate that taurine treatment after 3-NP administration protects the striatum from damage.


Asunto(s)
Astrocitos/efectos de los fármacos , Cuerpo Estriado/efectos de los fármacos , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Propionatos/farmacología , Taurina/farmacología , Animales , Antioxidantes/farmacología , Astrocitos/metabolismo , Convulsivantes/farmacología , Cuerpo Estriado/metabolismo , Proteína Ácida Fibrilar de la Glía/metabolismo , Inmunohistoquímica , Masculino , Neuronas/metabolismo , Nitrocompuestos , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Superóxido Dismutasa/metabolismo , Tasa de Supervivencia , Taurina/metabolismo
12.
Brain Res Dev Brain Res ; 127(1): 63-70, 2001 Mar 29.
Artículo en Inglés | MEDLINE | ID: mdl-11287065

RESUMEN

Programmed cell death (apoptosis) is an important mechanism shaping the size of different cell populations within the developing nervous system. In our study we used the NT2/D1 clone originally established from the Ntera 2 cell line to investigate the baseline levels of apoptosis in cultured postmitotic hNT (NT2-N) neurons previously treated for 3, 4 or 5 weeks with retinoic acid (RA) and compared it with apoptosis in NT2 precursors unexposed to RA. First, we examined whether different lengths of exposure to RA might affect baseline apoptotic rate in differentiating hNT neurons. Second, we investigated whether cultured hNT neurons, previously shown to possess dopaminergic characteristics, would be preferentially affected by apoptosis. Using the terminal deoxynucleotidyl transferase (tdt)-labeling technique we found that the postmitotic hNT neuronal cells exposed to RA demonstrated significantly higher numbers of apoptotic cells (12.5-15.8%) in comparison to rapidly dividing NT2 precursor cell line (3.6-4.4%) at both studied (1 and 5 days in vitro, DIV) time points. Similar apoptotic nuclear morphology, including a variable extent of nuclear fragmentation was observed in all examined hNT cultures. On the other hand, the incidence of apoptotic nuclei was rare in cultures of NT2 precursors not subjected to RA treatment. Combined immunocytochemistry for tyrosine hydroxylase (TH) and Hoechst staining revealed dopaminergic hNT neurons destined to die. Our double-labeling studies have demonstrated that only a subset of TH-positive hNT cells had condensed chromatin after 1 (approx. 15%) and 5 (approx. 20%) DIV. NT2 precursors were not TH-positive. Collectively, our results demonstrated that exposure to differentiating agent RA triggers an apoptotic commitment in a subset of postmitotic hNT neurons. These results suggest that this cell line may serve as a model of neuronal development to test various pathogenic factors implicated in the etiology of Parkinson's disease (PD), as well as to screen numerous pharmacological treatments that may slow or prevent dopaminergic deterioration.


Asunto(s)
Apoptosis/fisiología , Neuronas/citología , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , ADN Nucleotidilexotransferasa/análisis , Dopamina/fisiología , Humanos , Neoplasias de Células Germinales y Embrionarias , Neuronas/enzimología , Células Madre/citología , Células Madre/enzimología , Tretinoina/farmacología , Células Tumorales Cultivadas , Tirosina 3-Monooxigenasa/análisis
13.
Exp Neurol ; 167(2): 252-9, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11161613

RESUMEN

An alternative source of cells for neural transplantation and brain repair that has many characteristics of immature neurons is the hNT neuron, derived from an embryonal human teratocarcinoma (NTera2) cell line that is terminally differentiated in vitro with retinoic acid. The majority of hNT neurons are GABAergic in cell culture. We have determined the calcium-binding protein (CBP) phenotypes of hNT neurons for three CBPs, calretinin (CR), calbindin D-28K (CB), and parvalbumin (PV), in cell culture and after transplantation into the rat striatum. In cell culture, 95% of all cell profiles were human nuclear matrix antigen (NuMA) positive. PV-positive hNT neurons constituted 50% of all neuron-like profiles, with CB+ and CR+ constituting 14 and 6% of cells, respectively. In contrast, when the striatal grafts were examined after 30 days survival using confocal microscopy, only 10% of hNT neurons immunopositive for NuMA were PV+; 19% were CB+/NuMA+, approximately the same percentage as was seen in vitro, and 82% of grafted hNT neurons were CR+. These results suggest that hNT neurons can be subdivided into at least three subpopulations based on the CBP phenotype that they express and that there is a CBP phenotypic shift following transplantation. Three related hypotheses are proposed to account for this phenotypic shift of hNT neurons after transplantation: (a) selective survival of the CR+ subpopulation of hNT neurons, (b) selective transitory quiescence of the transplanted PV+ cells due to transplantation stress, or (c) dedifferentiation of the hNT neurons following transplantation, which may allow them to respond to local environmental cues during the engraftment process.


Asunto(s)
Proteínas de Unión al Calcio/biosíntesis , Cuerpo Estriado/cirugía , Células Madre Neoplásicas/trasplante , Neuronas/trasplante , Accidente Cerebrovascular/terapia , Animales , Antígenos Nucleares , Trasplante de Tejido Encefálico/métodos , Proteínas de Ciclo Celular , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Cuerpo Estriado/patología , Criopreservación , Células Madre de Carcinoma Embrionario , Femenino , Trasplante de Tejido Fetal/métodos , Supervivencia de Injerto , Humanos , Células Madre Neoplásicas/citología , Células Madre Neoplásicas/efectos de los fármacos , Células Madre Neoplásicas/metabolismo , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Proteínas Asociadas a Matriz Nuclear , Proteínas Nucleares/biosíntesis , Fenotipo , Ratas , Ratas Sprague-Dawley , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/cirugía , Teratocarcinoma , Trasplante Heterólogo , Tretinoina/farmacología , Tirosina 3-Monooxigenasa/biosíntesis
15.
Novartis Found Symp ; 231: 129-38; discussion 139-47, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11131535

RESUMEN

Huntington's disease is a fatal neurological disorder characterized by chorea and deterioration in cognitive and neuropsychiatric function. Primary pathological changes are found in the striatum, where GABAergic neurons undergo degenerative changes. Local interneurons are relatively spared. Here, we describe the rationale for clinical trials of fetal striatal tissue transplantation for the treatment of Huntington's disease. Specifically, the reasons for utilizing tissue derived from the far lateral aspect of the lateral ventricular eminence as a source of striatal tissue will be discussed.


Asunto(s)
Trasplante de Tejido Encefálico , Cuerpo Estriado/trasplante , Trasplante de Tejido Fetal , Enfermedad de Huntington/cirugía , Animales , Ensayos Clínicos como Asunto , Humanos
16.
Brain Res Bull ; 53(3): 263-8, 2000 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11113579

RESUMEN

The hNT neuron exhibits many characteristics of neuroepithelial precursor cells, making them an excellent model to study neuronal plasticity in vitro and in vivo. These cells express a number of neurotransmitters in vitro, including dopamine, gamma-aminobutyric acid and acetylcholine. However, there have been few reports of the neurotransmitters that hNT neurons express in vivo. The present study examined whether hNT neurons express the same neurotransmitters in vivo as they do in vitro. First, the expression of tyrosine hydroxylase (TH), glutamic acid decarboxylase (GAD), choline acetyltransferase (ChAT) and the human specific nuclear marker NuMA by hNT neurons was confirmed. Nineteen normal animals were then transplanted with 80,000 hNT neurons aimed at the striatum, hippocampus or cerebral cortex. Five additional animals received injections of medium. All animals received daily intraperitoneal injections of cyclosporine (10 mg/kg) and survived 30 days. Sections through the transplants were examined for NuMA-positive hNT neurons, and for the presence of the three neurotransmitter markers: TH, GAD and ChAT. The hNT neurons were found in the striatum and cortex. Of the hNT neurons found within the rat striatum, 33% were ChAT-positive. In the cortex, only 4% of the neurons expressed ChAT. No GAD-positive hNT neurons were detected at either site. No NuMA-positive neurons were found in the hippocampus. The implanted hNT neurons did not induce activation of astrocytes as determined by immunocytochemistry for glial fibrillary acidic protein (GFAP). Moreover, no hNT neuron was found to express GFAP in vivo. Together, these data suggest that the hNT neurons engraft in the new host tissue, maintain their neuronal identity and may be guided in differentiation according to local environmental cues.


Asunto(s)
Neuronas/química , Neurotransmisores/metabolismo , Animales , Antígenos Nucleares , Proteínas de Ciclo Celular , Trasplante de Células , Corteza Cerebral/química , Corteza Cerebral/cirugía , Colina O-Acetiltransferasa/análisis , Cuerpo Estriado/química , Cuerpo Estriado/cirugía , Proteína Ácida Fibrilar de la Glía/análisis , Glutamato Descarboxilasa/análisis , Supervivencia de Injerto , Hipocampo/química , Hipocampo/cirugía , Humanos , Inmunohistoquímica , Masculino , Neuronas/citología , Neuronas/trasplante , Neurotransmisores/genética , Proteínas Asociadas a Matriz Nuclear , Proteínas Nucleares/análisis , Fenotipo , Ratas , Ratas Sprague-Dawley , Trasplante Heterólogo , Tirosina 3-Monooxigenasa/análisis
17.
Brain Res Dev Brain Res ; 122(1): 87-90, 2000 Jul 30.
Artículo en Inglés | MEDLINE | ID: mdl-10915908

RESUMEN

We investigated the catecholaminergic nature of cultured hNT neurons previously treated either for 4 or 5 weeks with retinoic acid (RA). There were significantly more tyrosine hydroxylase (TH)-positive neurons (60%) in cultures treated for 4 weeks with RA compared to 5 week-treated cultures (

Asunto(s)
Dopamina/análisis , Dopamina/genética , Glicoproteínas de Membrana , Proteínas de Transporte de Membrana , Proteínas del Tejido Nervioso , Neuronas , Aldehído Deshidrogenasa/análisis , Antineoplásicos/farmacología , Proteínas Portadoras/análisis , Línea Celular , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática , Inmunohistoquímica , Técnicas In Vitro , Mesencéfalo/citología , Neuronas/química , Neuronas/citología , Neuronas/enzimología , Fenotipo , Receptores de Dopamina D2/análisis , Tretinoina/farmacología , Tirosina 3-Monooxigenasa/análisis
18.
Exp Neurol ; 163(1): 31-8, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10785441

RESUMEN

Neurons derived from the human teratocarcinoma cell line (hNT) establish structural polarity and a fully mature phenotype following transplantation into the rodent brain. Here we describe the transplantation of hNT cells into the anterior part of neonatal subventricular zone (SVZa), which is a prolific region of neuronal progenitor cells. Ordinarily, the progeny of endogenous or homotopically transplanted SVZa cells migrate to the olfactory bulb (OB) along a restricted pathway, the rostral migratory stream (RMS), and differentiate into interneurons. To compare the phenotype of cultured hNT cells to their transplanted cohorts, hNT cells labeled by the fluorescent dye PKH26 were cultured for 1 day and stained with cell-type-specific antibodies. Clusters as well as individual hNT cells were immunoreactive for TuJ1, an antibody that recognizes neuron-specific class III beta-tubulin. The distribution and phenotype of the transplanted hNT cells were examined. The majority of transplanted PKH26-labeled hNT cells were found at their site of implantation in the SVZa, while a small proportion of the transplanted hNT cells was situated in the migratory pathway leading to the OB and in the subependymal zone and granule cell layer of the olfactory bulb. Many of the transplanted hNT cells, both within the SVZa and within the RMS, revealed a neuronal phenotype. Collectively, these results reveal the capacity of hNT cells to respond, at least partially, to cues that ordinarily govern the migration of SVZa-derived cells and maintain their neuronal identity.


Asunto(s)
Trasplante de Células/métodos , Neuronas/trasplante , Compuestos Orgánicos , Prosencéfalo/citología , Animales , Animales Recién Nacidos , Diferenciación Celular/fisiología , Línea Celular , Movimiento Celular/fisiología , Supervivencia Celular/fisiología , Colorantes Fluorescentes/análisis , Supervivencia de Injerto/fisiología , Humanos , Neuronas/química , Neuronas/citología , Bulbo Olfatorio/citología , Fenotipo , Prosencéfalo/cirugía , Ratas
19.
Cell Transplant ; 9(5): 657-67, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11144962

RESUMEN

Cell transplantation into host brain requires a reliable cell marker to trace lineage and location of grafted cells in host tissue. The lacZ gene encodes the bacterial (E. coli) enzyme beta-galactosidase (beta-gal) and is commonly visualized as a blue intracellular precipitate following its incubation with a substrate, "X gal," in an oxidation reaction. LacZ is the "reporter gene" most commonly employed to follow gene expression in neural tissue or to track the fate of transplanted exogenous cells. If the reaction is not performed carefully-with adequate optimization and individualization of various parameters (e.g.. pH, concentration of reagents, addition of chelators, composition of fixatives) and the establishment of various controls--then misleading nonspecific background X-gal positivity can result, leading to the misidentification of cells. Some of this background results from endogenous nonbacterial beta-gal activity in discrete populations of neurons in the mammalian brain; some results from an excessive oxidation reaction. Surprisingly, few articles have empha sized how to recognize and to eliminate these potential confounding artifacts in order to maximize the utility and credibility of this histochemical technique as a cell marker. We briefly review the phenomenon in general, discuss a specific case that illustrates how an insufficiently scrutinized X-gal positivity can be a pitfall in cell transplantation studies, and then provide recommendations for optimizing the specificity and reliability of this histochemical reaction for discerning E. coli beta-gal activity.


Asunto(s)
Compuestos Cromogénicos/metabolismo , Galactósidos/metabolismo , Histocitoquímica/métodos , Indoles/metabolismo , Neuronas/trasplante , beta-Galactosidasa/genética , Animales , Artefactos , Encéfalo/metabolismo , Escherichia coli/genética , Fijadores , Expresión Génica , Genes Reporteros , Concentración de Iones de Hidrógeno , Ratones , Neuronas/metabolismo , Ratas , beta-Galactosidasa/metabolismo
20.
Cell Transplant ; 9(6): 751-8, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11202562

RESUMEN

Taurine acts as an antioxidant able to protect neurons from free radical-mediated cellular damage. Moreover, it modulates the immune response of astrocytes that participate in neurodegenerative processes. The objective of this study was to examine whether taurine can prevent or attenuate the host inflammatory response induced by the xenotransplantation of neurons derived from the human teratocarcinoma cell line (hNT neurons). Male Sprague-Dawley rats were treated IP with either saline or taurine. Animals from both groups were perfused on the 4th or 11th day and the saline or taurine was administered from the start of the study until the day prior to sacrifice. The brains were processed immunohistochemically using antibodies against glial fibrillary acidic protein (GFAP), microglia (OX42), and human nuclear matrix antigen (NuMA). In the saline group, NuMA labeling revealed small grafts on the 4th day and no surviving cells on the 11th day. However, in the group that received taurine there were surviving grafts at both time points. Strong immunoreactivity for GFAP and OX42 was detected in the saline group surrounding the transplant. These effects were reduced in animals receiving taurine. Taken together, these results demonstrated that taurine was able to facilitate graft survival and attenuate the immune response generated by the xenograft.


Asunto(s)
Neoplasias Encefálicas/tratamiento farmacológico , Cuerpo Estriado/patología , Degeneración Nerviosa/tratamiento farmacológico , Taurina/farmacología , Teratocarcinoma/tratamiento farmacológico , Animales , Antioxidantes/farmacología , Astrocitos/química , Astrocitos/metabolismo , Astrocitos/patología , Neoplasias Encefálicas/patología , Proteínas de Ciclo Celular , Cuerpo Estriado/metabolismo , Cuerpo Estriado/cirugía , Proteína Ácida Fibrilar de la Glía/análisis , Supervivencia de Injerto/efectos de los fármacos , Inmunohistoquímica , Masculino , Microglía/química , Microglía/metabolismo , Microglía/patología , Trasplante de Neoplasias , Degeneración Nerviosa/metabolismo , Degeneración Nerviosa/patología , Neuronas/metabolismo , Neuronas/patología , Proteínas Nucleares/análisis , Estrés Oxidativo , Ratas , Ratas Sprague-Dawley , Teratocarcinoma/patología , Trasplante Heterólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA